Evidence map›Paper›PMID 39195896›Full record

ArticleNature cardiovascular research2024

Aligning public and institutional incentives to advance biomedical research.

John S Chorba

Abstract read
PubMed Publisher
In one paragraph

Article in Nature cardiovascular research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

John S ChorbaDivision of Cardiology, Department of Medicine, University of California, San Francisco, Oakland, CA, USA. john.chorba@ucsf.edu.ORCID 0000-0002-6397-6348

Funding

Chemical Biology to Modulate PCSK9 and Treat AtherosclerosisR01HL146404 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHORBA, JOHN S · 2021 to 2024
$1.6M
Small molecule allosteric inhibitors of PCSK9 processing to phenocopy cardioprotective genetic variants.R61HL170383 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHORBA, JOHN S · 2023 to 2023
$538k
Sequence Specific Inhibition of Protein TranslationR21GM141609 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHORBA, JOHN S · 2021 to 2022
$444k
G. Harold and Leila Y. Mathers Foundation (G. Harold & Leila Y. Mathers Foundation) n/aMerck Company Foundation SEEDS AwardNHLBI NIH HHS R01 HL146404NHLBI NIH HHS R61 HL170383NIGMS NIH HHS R21 GM141609
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomedical ResearchMotivationHumansResearch Support as Topic

Identifiers

PMID39195896

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.